Articles from GAXOS.AI INC.

Roseland, NJ, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that it will participate in the upcoming Sequire Investor Summit on January 21st – 23rd in San Juan, Puerto Rico.

Gaxos.ai Inc. raises approximately $9 million in gross proceeds in December 2024

Roseland, NJ, Dec. 27, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. (Nasdaq: GXAI), (“Gaxos” or the “Company”), a company developing artificial intelligence applications across various sectors, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 1,346,669 shares of its common stock at a purchase price of $3.00 per share in a registered direct offering priced at-the-market under Nasdaq rules. In addition, in a concurrent private placement, the Company will issue unregistered warrants to purchase up to 1,346,669 shares of common stock. The warrants will have an exercise price of $3.00 per share, will be exercisable upon issuance and expire three years following the date of issuance. The closing of the offering is expected to occur on or about December 30, 2024, subject to the satisfaction of customary closing conditions.

Roseland, NJ, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that the Company successfully integrated Meshy 4 into their artificial intelligence solution for game developers and publishers, Gaxos Labs.

Roseland, NJ, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. (Nasdaq: GXAI), (“Gaxos” or the “Company”), a company developing artificial intelligence applications across various sectors, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules for the purchase and sale of an aggregate of 1,449,277 shares of its common stock at a purchase price of $3.45 per share. In addition, in a concurrent private placement, the Company issued unregistered warrants to purchase up to 1,449,277 shares of common stock. The warrants have an exercise price of $3.32 per share, are exercisable upon issuance and expire three years following the date of issuance. 

Roseland, NJ, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. (Nasdaq: GXAI), (“Gaxos” or the “Company”), a company developing artificial intelligence applications across various sectors, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 1,449,277 shares of its common stock at a purchase price of $3.45 per share in a registered direct offering priced at-the-market under Nasdaq rules. In addition, in a concurrent private placement, the Company will issue unregistered warrants to purchase up to 1,449,277 shares of common stock. The warrants will have an exercise price of $3.32 per share, will be exercisable upon issuance and expire three years following the date of issuance. The closing of the offering is expected to occur on or about December 20, 2024, subject to the satisfaction of customary closing conditions.

Roseland, NJ, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that the Company successfully integrated Recraft AI into their artificial intelligence solution for game developers and publishers, Gaxos Labs.

Roseland, NJ, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that the Company released a visual editor for Godot Engine for their artificial intelligence solution for game developers and publishers, Gaxos Labs. The Godot visual editor introduces a user-friendly interface that simplifies the process of embedding AI-driven features directly into game projects.

Roseland, NJ, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that the Company successfully integrated Suno AI and ElevenLabs into their artificial intelligence solution for game developers and publishers, Gaxos Labs.

Roseland, NJ, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, announced today that the Company’s Board of Directors approved the purchase of up to $1 million in Bitcoin. 

Roseland, NJ, Nov. 05, 2024 (GLOBE NEWSWIRE) --  Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that it will participate in the upcoming AI Summit New York on December 11th-12th in New York City.

Roseland, NJ, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that it will participate in the upcoming Game Industry Conference on October 24th - 27th in Poznan, Poland,

Roseland, NJ, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. (NASDAQGXAI), (“Gaxos” or the “Company”), a company developing artificial intelligence applications across various sectors, today announced that it has entered into a definitive agreement for the exercise of certain existing warrants to purchase an aggregate of 1,256,734 shares of its common stock originally issued in March 2024 and having an original exercise price of $5.50 per share, at a reduced exercise price of $2.58 per share. The issuance and sale of the shares of common stock issuable upon exercise of the existing warrants is registered pursuant to an effective registration statement on Form S-3 (File No. 333-278513).

Roseland, NJ, Sept. 13, 2024 (GLOBE NEWSWIRE) --  Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that it will participate in the upcoming Unite 2024 Conference on September 18th - 20th in Barcelona, Spain.

Roseland, NJ, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that it will participate in the upcoming Devcom Developer Conference on August 18th - Aug 20th and Gamescom Conference on August 21st – 25th in Cologne, Germany.

Significant Milestone as Company Transitions from Development to Revenue Generation.

Roseland, NJ, July 24, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that Gaxos Health has finalized partnerships with premier testing laboratories.

Roseland, NJ, July 10, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that it partnered with Meshy to deliver 3D assets in its AI solution for game developers and publishers.

Roseland, NJ, June 25, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that its gaming division, has successfully completed development of its AI solution for game developers and publishers.

Roseland, NJ, April 25, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that Gaxos Health has expanded its Medical Advisory Board with the appointment of Dr. Eric Margolis and Dr. Jeff Pavell.

Roseland, NJ, March 26, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. (NASDAQGXAI), (“Gaxos” or the “Company”), a company developing artificial intelligence applications across various sectors, announced today that it received written notice from the NASDAQ Stock Market LLC (NASDAQ) on March 22, 2024, informing the Company that it has regained compliance with the minimum bid price requirement under NASDAQ Listing Rule 5550(a)(2) for continued listing on the NASDAQ Capital Market.

Roseland, NJ, March 15, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. (NASDAQGXAI), (“Gaxos” or the “Company”), a company developing artificial intelligence applications across various sectors, announced today that it has closed its previously announced private placement for the purchase and sale of 628,367 shares of common stock (or pre-funded warrant in lieu thereof), series A warrants to purchase up to 628,367 shares of common stock and short-term series B warrants to purchase up to 628,367 shares of common stock at a purchase price of $5.57 per share (or per pre-funded warrant in lieu thereof) and accompanying warrants priced at-the-market under Nasdaq rules. The series A warrants and short-term series B warrants have an exercise price of $5.50 per share and are exercisable immediately upon issuance. The series A warrants expire five and one-half years from the date of issuance and short-term series B warrants expire twenty-four months from the date of issuance.

Roseland, NJ, March 13, 2024 (GLOBE NEWSWIRE) --  Gaxos.ai Inc. (NASDAQGXAI), (“Gaxos” or the “Company”), a company developing artificial intelligence applications across various sectors, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 628,367 shares of common stock (or pre-funded warrant in lieu thereof), series A warrants to purchase up to 628,367 shares of common stock and short-term series B warrants to purchase up to 628,367 shares of common stock at a purchase price of $5.57 per share (or per pre-funded warrant in lieu thereof) and accompanying warrants, in a private placement priced at-the-market under Nasdaq rules. The series A warrants and short-term series B warrants will have an exercise price of $5.50 per share and will be exercisable immediately upon issuance. The series A warrants will expire five and one-half years from the date of issuance and the short-term series B warrants will expire twenty-four months from the date of issuance. The private placement is expected to close on or about March 15, 2024, subject to the satisfaction of customary closing conditions.

Roseland, NJ, March 13, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that it had acquired the rights to use certain AI-enabled technology from a top biohacking app, “Ultiself,” in order to facilitate the development of its tech for Gaxos Health.

Roseland, NJ, March 06, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. (NASDAQGXAI), (“Gaxos” or the “Company”), a company developing artificial intelligence applications across various sectors, today announced that it will effect a 1-for-12 reverse split of its issued and outstanding common stock effective as of 4:01pm Eastern Time on March 7, 2024. Commencing with the opening of trading on The Nasdaq Capital Market on March 8, 2024, the Company’s common stock will trade on a post-split basis under the same trading symbol, “GXAI”.

Roseland, NJ, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that its health and wellness division, Gaxos Health, has formed a medical advisory board for providing invaluable insight into product development and creating strategic opportunities. The Company has appointed Dr. Nate Lebowitz, M.D. as the Chairman of the Advisory Board.

Roseland, NJ, Feb. 16, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that its gaming division, Gaxos Gaming, will launch an artificial intelligence (AI) solution for game developers and studios.

Roseland, NJ, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications various sectors, today announced a significant strategic expansion with Gaxos Health, a division dedicated to revolutionizing personal health and wellness.

Roseland, NJ, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Gaxos.AI ("Gaxos" or the "Company"), today unveils a groundbreaking initiative to revolutionize the world of artificial intelligence. Building on its legacy in gaming, Gaxos is set to launch a visionary suite of artificial intelligence applications, uniquely designed to enhance mental and physical health, combat loneliness, and promote longevity.

Roseland, NJ, Jan. 12, 2024 (GLOBE NEWSWIRE) -- Gaxos.AI ("Gaxos" or the "Company"), today unveils a groundbreaking initiative to revolutionize the world of artificial intelligence. Building on its legacy in gaming, Gaxos is set to launch a visionary suite of artificial intelligence applications, uniquely designed to enhance mental and physical health, combat loneliness, and promote longevity.